persistent atrial fibrillation
Conditions
Interventions
The study group: ethanol infusion of vein of Marshall+ "2C3L" ablation strategy
The control group:"2C3L" ablation strategy
Sponsors
Beijing Anzhen Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age =18 years and <80 years; (2) Patients with PeAF undergoing catheter ablation for the first time.
Exclusion criteria
Exclusion criteria: (1) Previous cardiac surgery or/and AF ablation; (2) History of rheumatic valve disease; (3) Ischaemic stroke or TIA within 6 months; (4) Contraindication to anticoagulation; (5) Inability to complete or contraindications to MRI, such as claustrophobia; (6) LA diameter >55 mm (parasternal long-axis view in transthoracic echocardiography); (7) Patients who could not complete the procedure due to complications; (8) Subjects who have participated in other drug or device clinical trials during the same period; (9) Abnormalities or diseases that, in the opinion of the investigator, should be excluded from enrolment in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cranial MRI ; | — |
Countries
China
Contacts
Public ContactDeyong Long
Beijing Anzhen Hospital, Capital Medical University
Outcome results
None listed